Ecolab Life Sciences has opened its new US Bioprocessing Applications Laboratory in King of Prussia, Pennsylvania.
The new facility aims to assist biopharma clients in application and process development for the purification of biotherapeutic molecules, offering extensive technical support to biopharmaceutical companies and contract manufacturers, whether for small-scale or full commercial production. Strategically located in the Eastern U.S., it is in proximity to numerous major pharmaceutical operations and serves as a center for bioprocessing innovation.
Equipped with high-throughput process development tools and chromatography columns suitable for manufacturing scale, the lab allows biotech companies to obtain comprehensive support for their process development efforts. Large biopharma organizations can leverage the applications lab throughout all phases of development, from early to late-stage efforts, including commercialization; this encompasses characterizing alternative resins to help cut down manufacturing costs and assisting with regulatory submissions.
“Our new Bioprocessing Applications Lab marks a significant milestone in our ability to be a global technical partner to our customers around the world,” said Jennifer Sorrells, Ph.D., vice president of research and development, Ecolab Life Sciences. “This facility demonstrates our commitment to delivering best-in-class bioprocessing solutions by pairing Ecolab’s innovative resin toolbox with deep domain expertise to optimize the purification process. We are dedicated to empowering our customers to accelerate the delivery of life-saving therapies to market.”
Biopharma and contract manufacturing organizations are already leveraging Ecolab’s Bioprocessing Applications Lab to help accelerate speed and enhance manufacturing efficiencies through lifecycle studies.
